Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on August 13, 2012. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Molecular Analysis of Fixed Paraffin-Embedded (FFPE) Tonsil Tumors

Awarded
NCI-120114-LGFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
SLED
Fire Flow Testing Services
Solicitation # 121589
The Washington Suburban Sanitary Commission (WSSC) is soliciting sealed responses for solicitation number 121589 to establish a Fire Flow Testing Services program. The contractor will be responsible for the planning, locating, inspection, and testing of fire hydrants and associated water distribution components across various pressure zones in Maryland to evaluate hydraulic performance. Key technical tasks include measuring static pressure, residual pressure, and flow rates, as well as performing traffic setup and maintenance for residential, county, and state roads. The project involves a base quantity of 1,500 fire flow tests, 3,000 hydrant inspections, and 3,000 valve inspections, with pricing options for three additional years. To be considered, bidders must possess at least five years of experience as a prime contractor and provide at least two crews, each led by a professional with three years of expertise. Crucially, at least one crew member must hold a current Maryland Water Distribution System Operator D-1 license. Bidders must also provide a comprehensive equipment list and adhere to AWWA and MDE standards, including specific requirements for chlorinated water discharge. The contract will be awarded to the lowest responsive and responsible bidder who meets all minimum qualifications. Submissions are due by November 30, 2026, via the WSSC eProcurement Portal. Contract administration includes strict quality assurance requirements, requiring the implementation of a QA/QC plan and immediate reporting of residual pressures falling below 20 psi. Contractors must maintain significant insurance coverages, including Commercial General Liability, Pollution Liability, and Errors and Omissions, each with limits up to 2,000,000 dollars. Payment is processed via ACH or procurement credit card within 30 days of acceptance. Additionally, the contract incorporates a Mid-Atlantic Purchasing Team clause, allowing other public entities to utilize the resultant contract terms and pricing.
Utility Services Department

POSTED

about 20 hours ago

DEADLINE

in about 1 month

AI Contract Overview

Show more

The National Cancer Institute's Division of Cancer Epidemiology and Genetics intends to award a sole source, firm fixed price contract to Oxford Gene Technology for the molecular analysis of 140 formalin fixed paraffin-embedded tonsil tumors. This project involves extracting DNA and performing array CGH using the Agilent platform to compare chromosomal aberrations in HPV positive tonsil tumors with existing data from cervical pre-cancerous lesions and invasive cancer. The specific contractor was selected to ensure data consistency and validity when compared to previous results from the SUCCEED study. The period of performance for this requirement is twelve months from the date of award. This acquisition falls under NAICS code 541380 and is being processed via simplified acquisition procedures. While the government intends to proceed on a sole source basis, interested parties were invited to submit written statements of capabilities by August 28, 2012, to demonstrate their ability to meet the unique technical specifications of the study.

General Info

Agency

N/A

Contract Value

$85,085

NAICS

541380 - Testing Laboratories and Services

Place of Performance

GBR

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Laura GlocknerContract Specialist

Full Description

Show more
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6070, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB), plans to procure on a sole source basis services from Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarton, Oxford, OX51PF, United Kingdom, for molecular analysis of fixed paraffin-embedded (FFPE) tonsil tumors. This acquisition will be processed in accordance with simplified acquisition procedures in FAR Part 13.106 (b)(1). The North American Industry Classification System code is 541380 the business size standard is $12.0 million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance: Performance shall be for twelve (12) months from date of award. It has been determined that there is no opportunity to acquire green products or services under this contract. The Division of Cancer Epidemiology and Genetics (DCEG) is an intramural research program of the National Cancer Institute (NCI) that conducts population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Infections and Immunoepidemiology Branch (IIB) conducts multidisciplinary studies of carefully selected domestic and foreign populations, with the goal of clarifying the relationship of infectious agents, especially viruses, to human cancer and other conditions. The IIB is comparing chromosomal aberrations of HPV positive tonsil tumors with cervical pre-cancerous lesions (CIN 3) and invasive cancer. The study will be conducted using tonsil tumor specimens from the Surveillance Epidemiology End Result study Residual Tissue Repository (SEER-RTR) study as well as CIN3 and cancer cases from the Study to Understand Cervical Cancer Endpoints and Early Determinants (SUCCEED) that were previously characterized using the CGH assay. The purpose of this requirement is to conduct molecular analyses on 140 formalin fixed paraffin-embedded (FFPE) tonsil tumors previously characterized for HPV DNA from the Surveillance Epidemiology End Result study Residual Tissue Repository (SEER-RTR). From the same cases, extracted DNA will be prepared for array CGH using the Agilent platform. Oxford Gene Technology is the only known contractor that can fulfill the requirements of this project. A primary objective of this study is to compare chromosomal alterations of tonsillar tissue with data previously collected from CIN 3 and cervical cancer patients in the SUCCEED study using the contractor designated above as part of a separate contract. Therefore, to assure accurate and valid comparisons of our results with previously collected data, it is imperative that Oxford Gene Technologies conducts this CGH testing and data collection. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisition on or before 11:00 AM EST on August 28, 2012. No electronic capability statements will be accepted (i.e. email or fax) an original and one copy must be sent to the NCI Office of Acquisition to the address stated above. All questions must be in writing and can be faxed +1 (555) 000-0000 or emailed to Laura Glockner, Contract Specialist at contact@example.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through SAM.gov. No collect calls will be accepted. Please reference solicitation number NCI-120114-LG on all correspondence.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS